Patents by Inventor Adam Heller
Adam Heller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240341639Abstract: Embodiments of the present disclosure include a method for receiving sensor data indicative of a glucose level from a glucose sensor configured to be positioned in contact with a bodily fluid under a skin surface of a subject, receiving, from a temperature sensor, temperature data indicative of a temperature of the skin surface, determining a rate of change of the glucose level, wherein the rate of change indicates a presence of a hypoglycemic condition, determining that a variation of the temperature of the skin surface is within a predetermined range of temperature values, and determining, in response to the variation of the temperature data, that the rate of change of the glucose level corresponds to a sensor signal attenuation.Type: ApplicationFiled: June 27, 2024Publication date: October 17, 2024Applicant: ABBOTT DIABETES CARE INC.Inventors: Benjamin Jay Feldman, Adam Heller, Namvar Kiaie
-
Publication number: 20240298935Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.Type: ApplicationFiled: May 20, 2024Publication date: September 12, 2024Applicant: ABBOTT DIABETES CARE INC.Inventors: Thomas A. Peyser, Adam Heller
-
Patent number: 12048530Abstract: Embodiments of the present disclosure include detecting a concurrent occurrence of a decrease in monitored analyte level and a corresponding decrease in monitored on-skin temperature, confirming a presence of an impending hypoglycemic condition, and asserting a notification corresponding to the confirmed impending hypoglycemic condition. Devices, methods, systems and kits incorporating the same are also provided.Type: GrantFiled: December 27, 2021Date of Patent: July 30, 2024Assignee: ABBOTT DIABETES CARE INC.Inventors: Benjamin Jay Feldman, Adam Heller, Namvar Kiaie
-
Patent number: 11911151Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.Type: GrantFiled: October 6, 2022Date of Patent: February 27, 2024Assignee: Abbott Diabetes Care Inc.Inventors: Thomas A. Peyser, Adam Heller
-
Publication number: 20240009433Abstract: The invention features methods for continuously administering a drug by oral infusion (e.g., via a drug delivery device anchored in the mouth for continuously administering a pharmaceutical composition), and pre-screening subjects and, if necessary, treating subjects with H. pylori to improve the PK performance of the continuous intraoral administration in the subject.Type: ApplicationFiled: September 13, 2021Publication date: January 11, 2024Inventor: Adam HELLER
-
Publication number: 20230355939Abstract: Devices and methods are disclosed for continuous extrusion of a drug-containing fluid into the mouth of a patient from a device residing in the mouth of the patient. Methods of treating a disease by such extrusion are also disclosed.Type: ApplicationFiled: September 15, 2021Publication date: November 9, 2023Inventors: Adam HELLER, John SPIRIDIGLIOZZI, Steven DIIANNI, Robert DRAPER, John HOWARD
-
Publication number: 20230181506Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.Type: ApplicationFiled: July 15, 2022Publication date: June 15, 2023Inventors: Adam HELLER, Ephraim HELLER, John SPIRIDIGLIOZZI, Steven DIIANNI, Karl Göran WESTERBERG
-
Patent number: 11471075Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.Type: GrantFiled: April 7, 2022Date of Patent: October 18, 2022Assignee: ABBOTT DIABETES CARE INC.Inventors: Thomas A. Peyser, Adam Heller
-
Patent number: 11426376Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.Type: GrantFiled: September 21, 2021Date of Patent: August 30, 2022Assignee: SynAgile CorporationInventors: Adam Heller, Ephraim Heller, John Spiridigliozzi, Steven Diianni, Karl Göran Westerberg
-
Patent number: 11399748Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.Type: GrantFiled: November 18, 2021Date of Patent: August 2, 2022Assignee: ABBOTT DIABETES CARE INC.Inventors: Thomas A. Peyser, Adam Heller
-
Publication number: 20220225907Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.Type: ApplicationFiled: April 7, 2022Publication date: July 21, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Thomas A. Peyser, Adam Heller
-
Patent number: 11363975Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.Type: GrantFiled: November 15, 2021Date of Patent: June 21, 2022Assignee: ABBOTT DIABETES CARE INC.Inventors: Thomas A. Peyser, Adam Heller
-
Publication number: 20220117522Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.Type: ApplicationFiled: November 18, 2021Publication date: April 21, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Thomas A. Peyser, Adam Heller
-
Publication number: 20220117523Abstract: Embodiments of the present disclosure include detecting a concurrent occurrence of a decrease in monitored analyte level and a corresponding decrease in monitored on-skin temperature, confirming a presence of an impending hypoglycemic condition, and asserting a notification corresponding to the confirmed impending hypoglycemic condition. Devices, methods, systems and kits incorporating the same are also provided.Type: ApplicationFiled: December 27, 2021Publication date: April 21, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Benjamin Jay Feldman, Adam Heller, Namvar Kiaie
-
Patent number: 11272867Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.Type: GrantFiled: August 30, 2021Date of Patent: March 15, 2022Assignee: ABBOTT DIABETES CARE INC.Inventors: Thomas A. Peyser, Adam Heller
-
Publication number: 20220071525Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.Type: ApplicationFiled: November 15, 2021Publication date: March 10, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Thomas A. Peyser, Adam Heller
-
Publication number: 20220000823Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.Type: ApplicationFiled: September 21, 2021Publication date: January 6, 2022Inventors: Adam HELLER, Ephraim HELLER, John SPIRIDIGLIOZZI, Steven DIIANNI, Karl Göran WESTERBERG
-
Patent number: 11207005Abstract: Embodiments of the present disclosure include detecting a concurrent occurrence of a decrease in monitored analyte level and a corresponding decrease in monitored on-skin temperature, confirming a presence of an impending hypoglycemic condition, and asserting a notification corresponding to the confirmed impending hypoglycemic condition. Devices, methods, systems and kits incorporating the same are also provided.Type: GrantFiled: November 5, 2018Date of Patent: December 28, 2021Assignee: Abbott Diabetes Care Inc.Inventors: Benjamin Jay Feldman, Adam Heller, Namvar Kiaie
-
Publication number: 20210386336Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.Type: ApplicationFiled: August 30, 2021Publication date: December 16, 2021Applicant: ABBOTT DIABETES CARE INC.Inventors: Thomas A. Peyser, Adam Heller
-
Patent number: 11135191Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.Type: GrantFiled: September 24, 2020Date of Patent: October 5, 2021Assignee: SynAgile CorporationInventors: Adam Heller, Ephraim Heller, John Spiridigliozzi, Steven Diianni, Evangelos C. Eleftheriou